Man Group PLC Adaptimmune Therapeutics PLC Transaction History

Man Group PLC

$36 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.73 - $4.06 $234,494 - $550,316	-135,546 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.5 - $5.68 $44,656 - $72,471	-12,759 Reduced 8.6%	135,546 $508,000
Q3 2021 Nov 15, 2021	BUY	$3.44 - $6.37 $156,303 - $289,433	45,437 Added 44.17%	148,305 $767,000
Q2 2021 Aug 16, 2021	SELL	$3.86 - $5.78 $124,847 - $186,948	-32,344 Reduced 23.92%	102,868 $438,000
Q1 2021 May 17, 2021	BUY	$4.9 - $6.83 $155,526 - $216,784	31,740 Added 30.67%	135,212 $718,000
Q4 2020 Feb 16, 2021	BUY	$4.0 - $9.2 $119,276 - $274,334	29,819 Added 40.49%	103,472 $558,000
Q3 2020 Nov 16, 2020	BUY	$7.66 - $10.78 $279,574 - $393,448	36,498 Added 98.23%	73,653 $588,000
Q2 2020 Aug 14, 2020	BUY	$2.58 - $12.1 $8,599 - $40,329	3,333 Added 9.85%	37,155 $372,000
Q1 2020 May 15, 2020	SELL	$1.2 - $4.52 $1.26 Million - $4.75 Million	-1,050,981 Reduced 96.88%	33,822 $92,000
Q4 2019 Feb 18, 2020	SELL	$0.72 - $1.43 $694,702 - $1.38 Million	-964,865 Reduced 47.07%	1,084,803 $1.3 Million
Q3 2019 Nov 14, 2019	BUY	$1.43 - $3.81 $300,933 - $801,787	210,443 Added 11.44%	2,049,668 $3.1 Million
Q2 2019 Aug 14, 2019	BUY	$3.23 - $5.41 $1.62 Million - $2.71 Million	500,595 Added 37.4%	1,839,225 $7.39 Million
Q1 2019 May 15, 2019	BUY	$3.63 - $6.06 $1.07 Million - $1.79 Million	294,619 Added 28.22%	1,338,630 $5.76 Million
Q4 2018 Feb 14, 2019	BUY	$3.76 - $14.16 $2.43 Million - $9.13 Million	645,109 Added 161.72%	1,044,011 $6 Million
Q3 2018 Nov 14, 2018	BUY	$8.27 - $13.56 $3.3 Million - $5.41 Million	398,902 New	398,902 $5.41 Million

Others Institutions Holding ADAP

# of Institutions

Shares Held

150M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$23.4 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$17 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$10.6 Million
1.24% of portfolio
Baillie Gifford & CO

16.8M
Shares

$10.4 Million
0.01% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$8.25 Million
0.46% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $101M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account